MEZIGDOMIDE |
MEZIGDOMIDE : Degrader of CRBN
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| CRBN |
|
|
Degrader, CELMoD
up to 100 nM
Selectivity
Potency Cellular
In Vitro
CRBN
Mode of Action: Degrader, CELMoD
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acs.jmedchem.9b01928
In Vivo Validations
Rat
Dose: 2 mg/Kg
Route of delivery:
Intravenous
Systemic clearance:
6.8 ± 1.0 mL/min/Kg
DOI Reference: 10.1021/acs.jmedchem.9b01928
Dose: 10 mg/Kg
Route of delivery:
Oral
Cmax:
3.2 ± 0.5 uM
Tmax:
0.8 ± 0.3 h
Area Under the Curve::
16.4 ± 6.8 uM*h
Bioavailability:
38% ± 17%
DOI Reference: 10.1021/acs.jmedchem.9b01928
Monkey (Cynomolgus)
Dose: 3 mg/Kg
Route of delivery:
Oral
Cmax:
0.22 ± 0.08 uM
Area Under the Curve::
1.1 ± 0.3 uM*h
DOI Reference: 10.1021/acs.jmedchem.9b01928
Negative Control Compounds
Chemical Information
| Molecular Formula | C32H30FN5O4 |
| SMILEs | N#Cc1ccc(N2CCN(Cc3ccc(COc4cccc5c4CN([C@H]4CCC(=O)NC4=O)C5=O)cc3)CC2)c(F)c1 |
| InChI | InChI=1S/C32H30FN5O4/c33-26-16-23(17-34)8-9-27(26)37-14-12-36(13-15-37)18-21-4-6-22(7-5-21)20-42-29-3-1-2-24-25(29)19-38(32(24)41)28-10-11-30(39)35-31(28)40/h1-9,16,28H,10-15,18-20H2,(H,35,39,40)/t28-/m0/s1 |
| Molecular weight | 567.23 Da |
| AlogP | 0.0 |
| HBond acceptors | 9 |
| HBond donors | 1 |
| Atoms | 72 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.